HyHub? and HyHub? Duo Vial Access Devices
Jul 2025
259d
Takeda Pharmaceuticals
1
Total
1
Cleared
0
Denied
Takeda Pharmaceuticals — FDA 510(k) Submissions
Takeda Pharmaceuticals has submitted 1 FDA 510(k) premarket notifications since 2025, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Set, I.v. Fluid Transfer . Use the specialty filter in the sidebar to narrow results.
1 devices